| Original Research Online Published: 20 Sep 2021 | ||||||||||||
A participant centered surveillance of adverse events following coronavirus disease immunization phase 1 at a tertiary care teaching hospital Ruchita J Mer, Gaurav G Kakasaniya, Tejas A Acharya, Dimple S Mehta.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Mer RJ, Kakasaniya GG, Acharya TA, Mehta DS. A participant centered surveillance of adverse events following coronavirus disease immunization phase 1 at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol. 2022; 12(3): 312-316. doi:10.5455/njppp.2022.12.08308202106092021 Web Style Mer RJ, Kakasaniya GG, Acharya TA, Mehta DS. A participant centered surveillance of adverse events following coronavirus disease immunization phase 1 at a tertiary care teaching hospital. https://www.njppp.com/?mno=115631 [Access: November 02, 2024]. doi:10.5455/njppp.2022.12.08308202106092021 AMA (American Medical Association) Style Mer RJ, Kakasaniya GG, Acharya TA, Mehta DS. A participant centered surveillance of adverse events following coronavirus disease immunization phase 1 at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol. 2022; 12(3): 312-316. doi:10.5455/njppp.2022.12.08308202106092021 Vancouver/ICMJE Style Mer RJ, Kakasaniya GG, Acharya TA, Mehta DS. A participant centered surveillance of adverse events following coronavirus disease immunization phase 1 at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol. (2022), [cited November 02, 2024]; 12(3): 312-316. doi:10.5455/njppp.2022.12.08308202106092021 Harvard Style Mer, R. J., Kakasaniya, . G. G., Acharya, . T. A. & Mehta, . D. S. (2022) A participant centered surveillance of adverse events following coronavirus disease immunization phase 1 at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol, 12 (3), 312-316. doi:10.5455/njppp.2022.12.08308202106092021 Turabian Style Mer, Ruchita J, Gaurav G Kakasaniya, Tejas A Acharya, and Dimple S Mehta. 2022. A participant centered surveillance of adverse events following coronavirus disease immunization phase 1 at a tertiary care teaching hospital. National Journal of Physiology, Pharmacy and Pharmacology, 12 (3), 312-316. doi:10.5455/njppp.2022.12.08308202106092021 Chicago Style Mer, Ruchita J, Gaurav G Kakasaniya, Tejas A Acharya, and Dimple S Mehta. "A participant centered surveillance of adverse events following coronavirus disease immunization phase 1 at a tertiary care teaching hospital." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 312-316. doi:10.5455/njppp.2022.12.08308202106092021 MLA (The Modern Language Association) Style Mer, Ruchita J, Gaurav G Kakasaniya, Tejas A Acharya, and Dimple S Mehta. "A participant centered surveillance of adverse events following coronavirus disease immunization phase 1 at a tertiary care teaching hospital." National Journal of Physiology, Pharmacy and Pharmacology 12.3 (2022), 312-316. Print. doi:10.5455/njppp.2022.12.08308202106092021 APA (American Psychological Association) Style Mer, R. J., Kakasaniya, . G. G., Acharya, . T. A. & Mehta, . D. S. (2022) A participant centered surveillance of adverse events following coronavirus disease immunization phase 1 at a tertiary care teaching hospital. National Journal of Physiology, Pharmacy and Pharmacology, 12 (3), 312-316. doi:10.5455/njppp.2022.12.08308202106092021 |
